Skip to main content
AHR
NYSE Real Estate & Construction

CEO Takes Medical Leave Due to Health Event; Chairman Appointed Interim CEO

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$46.82
Mkt Cap
$9.034B
52W Low
$26.48
52W High
$51.015
Market data snapshot near publication time

Summary

American Healthcare REIT's CEO, Danny Prosky, is taking a medical leave of absence, with Chairman Jeffrey T. Hanson stepping in as Interim CEO and President.


Key Events

  • CEO Takes Medical Leave

    Danny Prosky, the Chief Executive Officer, President, and a director of American Healthcare REIT, Inc., has taken a medical leave of absence effective February 3, 2026, due to a recent medical event.

  • Interim CEO Appointed

    Jeffrey T. Hanson, the current Chairman of the Board and former Chief Executive Officer (2015-2021), has been appointed Interim Chief Executive Officer and President, effective February 3, 2026.


Analysis

The unexpected medical leave of the Chief Executive Officer and President, Danny Prosky, introduces leadership uncertainty for American Healthcare REIT. While the appointment of Jeffrey T. Hanson, the current Chairman and former CEO, as interim leader provides a degree of stability and continuity, the underlying health event for a key executive is a significant concern for investors. This event will likely prompt scrutiny of the company's succession planning and operational resilience during this transition period.

At the time of this filing, AHR was trading at $46.82 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $9B. The 52-week trading range was $26.48 to $51.02. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AHR - Latest Insights

AHR
May 28, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $49.46
Real-time Price: $46.81 info
Change: -$2.65 (-5%) info
Market Cap: $9.767B info
AHR
May 28, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $49.46
Real-time Price: $46.81 info
Change: -$2.65 (-5%) info
Market Cap: $9.767B info
AHR
May 22, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $50.19
Real-time Price: $46.81 info
Change: -$3.38 (-7%) info
Market Cap: $9.767B info
AHR
May 22, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $50.19
Real-time Price: $46.81 info
Change: -$3.38 (-7%) info
Market Cap: $9.767B info
AHR
May 20, 2026, 4:09 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $50.80
Real-time Price: $46.81 info
Change: -$3.99 (-8%) info
Market Cap: $9.767B info
AHR
May 08, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $51.71
Real-time Price: $46.81 info
Change: -$4.90 (-9%) info
Market Cap: $9.767B info
AHR
May 07, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $49.60
Real-time Price: $46.81 info
Change: -$2.79 (-6%) info
Market Cap: $9.767B info
AHR
May 07, 2026, 4:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $49.60
Real-time Price: $46.81 info
Change: -$2.79 (-6%) info
Market Cap: $9.767B info
AHR
Apr 09, 2026, 4:18 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $49.11
Real-time Price: $46.81 info
Change: -$2.30 (-5%) info
Market Cap: $9.767B info
AHR
Apr 07, 2026, 4:39 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $47.60
Real-time Price: $46.81 info
Change: -$0.790 (-2%) info
Market Cap: $9.767B info